Acrolein-induced vasomotor responses of rat aorta

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 285, Issue 2 54-2, 2003, Pages

  Tsakadze, Nina L ^a   Srivastava, Sanjay ^a   Awe, Sunday O ^a   Adeagbo, Ayotunde S O ^a   Bhatnagar, Aruni ^a   D'Souza, Stanley E ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Aldehydes; Nitric oxide; Rat aortic rings; Vasoreactivity

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; ACROLEIN; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); ALDEHYDE; GUANYLATE CYCLASE INHIBITOR; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OUABAIN; PHENYLEPHRINE; PROSTACYCLIN; QUINOXALINE DERIVATIVE; TETRABUTYLAMMONIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG MECHANISM; LIPID PEROXIDATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTILITY; VASCULAR RING; VASODILATATION; VASOMOTOR REFLEX;

EID: 0037962196     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00269.2003     Document Type: Article

References (51)

1. Adams JD Jr and Klaidman LK. Acrolein-induced oxygen radical formation. Free Radic Biol Med 15: 187-193, 1993.
2. Adeagbo ASO and Triggle CR. Effects of some inorganic divalent cations and protein kinase C inhibitors on endothelium-dependent relaxation in rat isolated aorta and mesenteric arteries. J Cardiovasc Pharmacol 18: 511-521, 1991.
3. Adeagbo ASO and Triggle CR. Interactions of nitric oxide synthase inhibitors and dexamethasone with α-adrenoceptor-mediated responses in rat aorta. Br J Pharmacol 109: 495-501, 1993.
4. Beauchamp RO, Andjelkovich DA, Kligerman AD, Morgan KT, and Heck HA. A critical review of literature on acrolein toxicity. Crit Rev Toxicol 14: 309-380, 1985.
5. Biswal S, Acquaah-Mensah G, Datta K, Wu X, and Kehrer JP. Inhibition of cell proliferation and AP-1 activity in human A549 lung adenocarcinoma cells due to thiol imbalance and covalent modifications. Chem Res Toxicol 15: 80-186, 2002.
6. Boor PJ and Hysmith RM. Allylamine cardiovascular toxicity: a review. Toxicology 44: 29-144, 1987.
7. Boulton CL, Southam E, and Garthwaite J. Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase. Neuroscience 69: 699-703, 1995.
8. Calingasan NY, Uchida K, and Gibson GE. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease. J Neurochem 72: 751-756, 1999.
9. 2-propanodeoxyguanosine adducts in DNA upon reaction with acrolein or crotonaldehyde. Cancer Res 44, 990-995, 1984.
10. Comporti M. Three models of free radical-induced cell injury. Chem Biol Interact 7: 333-349, 1989.
11. Conklin DJ and Boor PJ. Allylamine cardiovascular toxicity: evidence for aberrant vasoreactivity in rats. Toxicol Appl Pharmacol 148: 245-251, 1998.
12. Conklin DJ, Boyce CL, Trent MB, and Boor PJ. Amine metabolism: a novel path to coronary artery vasospasm. Toxicol Appl Pharmacol 175: 149-159, 2001.
13. Deckert V, Lizard G, Duverger N, Athias A, Palleau V, Emmanuel F, Moisant M, Gambert P, Lallemant C, and Lagrost L. Impairment of endothelium-dependent relaxation by high-fat feeding in Apo-E-deficient mice. Circulation 100: 1230-1235, 1999.
14. De Nucci G, Grygleweski RJ, Warner TD, and Vane JR. Receptor-mediated release of endothelium-derived relaxing factor and prostacyclin from bovine aortic endothelial cells is coupled. Proc Natl Acad Sci USA 85: 2334-2338, 1988.
15. Doupnik CA and Leikauf GD. Acrolein stimulates eicasanoid release from bovine airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 259: L222-L229, 1990.
16. D'Uscio LV, Baker TA, Mantilla CB, Smith L, Weiler D, Sieck GC, and Katusic ZS. Mechanism of endothelial dysfunction in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 21: 1017-1022, 2001.
17. Engler MB, Ma YH, and Engler MM. Calcium-mediated mechanisms of eicosapentaenoic acid-induced relaxation in hypertensive rat aorta. Am J Physiol 12: 1225-1235, 1999.
18. Esterbauer H, Schaur RJ, and Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 11: 81-128, 1991.
19. Foley TD. The cyclooxygenase hydroperoxide product PGG(2) activates synaptic nitric oxide synthase: a possible antioxidant response to membrane lipid peroxidation. Biochem Biophys Res Commun 286: 235-238, 2001.
20. Freischlag JA, Johnson D, Farooq MM, Doty J, Cambria RA, Seabrook GR, and Towne JB. Cigarette smoke impairs endothelium-dependent relaxation in rabbit superficial femoral veins. J Surg Res 81: 77-80, 1999.
21. Ghirdalucci DP and Tjeerdema RS. Fate and effects of acrolein. Rev Environ Contam Toxicol 144: 95-146, 1995.
22. Grafstrom RC, Dypbukt JM, Willey JC, Sundquist K, Edman C, Atzori L, and Harris CC. Pathobiological effects of acrolein in cultured human bronchial epithelial cells. Cancer Res 48: 1717-1721, 1988.
23. Haberland ME, Fong D, and Cheng L. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits. Science 241: 215-218, 1988.
24. Heistad DD, Armstrong ML, Marcus ML, Piegors DJ, and Mark AL. Augmented responses to vasoconstrictor stimuli in hypercholesterolemic and atherosclerotic monkeys. Circ Res 54: 711-718, 1984.
25. Horton ND, Mamiya BM, and Kehrer JP. Relationship between cell density, glutathione, and proliferation of A549 human lung adenocarcinoma cells treated with acrolein. Toxicology 122: 111-122, 1997.
26. Jaeschke H, Kleinwaechter C, and Wendel A. The role of acrolein in allyl-alcohol-induced lipid peroxidation and liver cell damage in mice. Biochem Pharmacol 36: 51-57, 1987.
27. Kachel DL and Martin 2nd WJ. Cyclophosphamide-induced lung toxicity: mechanism of endothelial injury. J Pharmacol Exp Ther 268: 42-46, 1994.
28. Katusic ZS, Schugel J, Consentino F, and Vanhoutte PM. Endothelium-dependent contractions to oxugen-derived free radicals in the canine basilar artery. Am J Physiol Heart Circ Physiol 264: H859-H864, 1993.
29. Kehrer JP and Biswal SS. The molecular effects of acrolein. Toxicol Sci 57: 6-15, 2000.
30. Martinez MC, Bosch-Morell F, Raya A, Roma J, Aldasoro M, Vila J, Lluch S, and Romero FJ. 4-Hydroxynonenal, a lipid peroxidation product, induces relaxation of human cerebral arteries. J Cereb Blood Flow Metab 14: 693-696, 1994.
31. Nogawa S, Forster C, Zhang F, Nagayama M, Ross ME, and Iadecola C. Interaction between inducible nitric oxide synthase and cyclooxygenase-2 after cerebral ischemia. Proc Natl Acad Sci USA 95: 10966-10971, 1998.
32. Patel JM and Block ER. Acrolein-induced injury to cultured pulmonary artery endothelial cells. Toxicol Appl Pharmacol 122: 46-53, 1993.
33. Ramos KS. Redox regulation of c-Ha-ras and osteopontin signaling in vascular smooth muscle cells: implications in chemical atherogenesis. Annu Rev Pharmacol Toxicol 39: 243-265, 1999.
34. Ribeiro RA, Freitas HC, Campos MC, Santos CC, Figuriedo FC, Brito GA, and Cunha FQ. Tumor necrosis factor-alpha and interleukin-lbeta mediate the production of nitric oxide involved in the pathogenesis of ifosfamide induced hemorrhagic cystitis in mice. J Urol 167: 2229-2234, 2002.
35. Romero FJ, Romero MJ, Bosch-Morell F, Martinez MC, Medina P, and Lluch S. 4-Hydroxynonenal-induced relaxation of human mesenteric arteries. Free Radic Biol Med 23: 521-523, 1997.
36. Rosenfeld ME, Palinski W, Ylä-Herttuala S, Butler S, and Witztum JL. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits. Arteriosclerosis 10: 336-349, 1990.
37. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809, 1993.
38. Rudra PK and Krokan HE. Acrolein cytotoxicity and glutathione depletion in n-3 fatty acid-sensitive and -resistant human tumor cells. Anticancer Res 19: 461-469, 1999.
39. Salvemini D, Misko TP, Masferrer JL, Seibert K, Currie MG, and Needleman P. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad Sci USA 90: 7240-7244, 1993.
40. Selley ML, Bartlett MR, McGuiness JA, and Ardlie NG. Effects of acrolein on human platelet aggregation. Chem Biol Interact 76: 101-109, 1990.
41. Shinmura K, Tang XL, Wang Y, Xuan YT, Liu SQ, Takano H, Bhatnagar A, and Bolli R. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci USA 97: 10197-10202, 2000.
42. Shinmura K, Xuan YT, Tang XL, Kodani E, Han H, Zhu Y, and Bolli R. Inducible nitric oxide synthase modulates cyclooxygenase-2 activity in the heart of conscious rabbits during the late phase of ischemic preconditioning. Circ Res 90: 602-608, 2002.
43. Suzuki D and Miyata T. Carbonyl stress in the pathogenesis of diabetic nephropathy. Intern Med 38: 309-314, 1999.
44. Torasson M, Luken ME, Breitenstein M, Krueger JA, and Biagini RE. Comparative toxicity of allylamine and acrolein in cultured myocytes and fibroblasts from neonatal rat heart. Toxicology 56: 107-117, 1989.
45. Uchida K. Current status of acrolein as a lipid peroxidation product. Trends Cardiovasc Med 9: 109-113, 1999.
46. Uchida K, Kanematsu M, Sakai K, Matsuda T, Hattori N, Mizuno Y, Suzuki D, Miyata T, Noguchi N, Niki E, and Osawa T. Protein-bound acrolein: potential marker for oxidative stress. Proc Natl Acad Sci USA 95: 4882-4887, 1998.
47. Vane JR, Anggard EEA, and Botting RM. Regulatory functions of the vascular endothelium. N Engl J Med 323: 27-36, 1990.
48. Verbeuren TJ, Jordans FH, Zonnekeyn LL, Van Hove CE, Coene MC, and Herman AG. Effect of hypercholesterolemia on vascular reactivity in the rabbit. I. Endothelium-dependent and endothelium-independent contraction and relaxation in isolated arteries of control and hypercholesterolemic rabbits. Circ Res 58: 552-564, 1986.
49. Witz G. Biological interactions of alpha, beta-unsaturated aldehydes. Free Radic Biol Med 7: 333-349, 1989.
50. Zeiher AM, Drexler H, Wollschlager H, and Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391-401, 1991.
51. Zhu BQ and Parmley WW. Hemodynamic and vascular effects of active and passive smoking. Am Heart J 130: 1270-1275, 1995.